Where Will Pacific Biosciences of California Inc (PACB) Stock Go Next After It Is Higher By 9.13% in a Week?

Overall market sentiment has been high on Pacific Biosciences of California Inc (PACB) stock lately. PACB receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Pacific Biosciences of California Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on PACB!

See Full PACB Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With PACB Stock Today?

Pacific Biosciences of California Inc (PACB) stock is trading at $13.62 as of 12:38 PM on Monday, Jun 5, a gain of $0.13, or 0.95% from the previous closing price of $13.49. The stock has traded between $13.37 and $13.89 so far today. Volume today is light. So far 1,551,474 shares have traded compared to average volume of 3,568,549 shares. To see InvestorsObserver's Sentiment Score for Pacific Biosciences of California Inc click here.

More About Pacific Biosciences of California Inc

Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe. Click Here to get the full Stock Report for Pacific Biosciences of California Inc stock.